Last reviewed · How we verify
NCT05465109: TACSI
Traumatic Brain Injury and Alzheimer's Disease/Related Dementias Caregiver Support Intervention
NA trial testing TBI-AD/ADRD Caregiver Support Intervention (TACSI) in Caregiver Burden in 95 participants. Completed in 28 June 2025.
28 June 2025
Quick facts
| Lead sponsor | University of Minnesota |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | supportive care |
| Enrollment | 95 |
| Start date | 1 July 2022 |
| Primary completion | 28 June 2025 |
| Estimated completion | 28 June 2025 |
| Sites | 1 location across United States |
Drugs / interventions tested
- TBI-AD/ADRD Caregiver Support Intervention (TACSI)
Conditions studied
- Caregiver Burden — all drugs for Caregiver Burden →
- Caregiver Stress Syndrome — all drugs for Caregiver Stress Syndrome →
- Caregiver Burnout — all drugs for Caregiver Burnout →
Sponsor
University of Minnesota
Who can join
21 and older, any sex, with Caregiver Burden or Caregiver Stress Syndrome. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The TBI-AD/ADRD Caregiver Support Intervention (TACSI) incorporates psychosocial and psychoeducational approaches with the objective of: a) identifying stressors associated with caregiving for family members who have the dual diagnosis of traumatic brain injury and dementia; and b) supporting caregivers in developing more effective coping and communication strategies as well as enhanced caregiving self-efficacy.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05465109
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Caregiver Burden
Currently open trials in the same condition.
- NCT06418971 — Testing & Refinement of CarePair: An Assessment and Referral Platform to Support Family Caregivers of Alzheimer's Diseas · NA · recruiting
- NCT07153016 — LEgal Guidance and AdvocaCY for CAREgivers (LEGACY CARE): A Pilot Clinical Trial for Caregivers of Persons With Colorect · NA · recruiting
- NCT07168577 — Sleep Quality and Caregiver Burden in Children With Cerebral Palsy · recruiting
- NCT07528261 — ACT Group for Stroke Caregivers · NA · recruiting
- NCT06367556 — Emotion and Symptom-Focused Engagement (EASE) for Caregivers · NA · recruiting
Other University of Minnesota trials
Trials by the same sponsor.
- NCT02421497 — MRI Technical Development and Applications in Kidney Disease · not yet recruiting
- NCT04100109 — Evaluating the Metabolic Effects of Polylactose: A Novel Prebiotic · NA · withdrawn
- NCT05454306 — Anser Clavicle Pin for Surgical Management of Midshaft Clavicle Fractures · NA · withdrawn
- NCT03192007 — Multi-Parametric MRI for Renal Transplantation · not yet recruiting
- NCT04940533 — Pharmacokinetics of CFTR Modulators in Pregnant Individuals and in Postpartum Breastfeeding Mothers · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05465109 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Minnesota
- Last refreshed: 22 December 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05465109.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing